More
    Guided Solutions - Connecting Talent With Innovation/div>

    Neurolyser XR now FDA cleared for sale in USA.

    FUSMobile announced that it received De Novo marketing authorization (DEN250015) from the FDA to begin marketing and sales of the Neurolyser XR system for the non-invasive treatment of low back pain. The Neurolyser XR is...

    Neurolyser XR now FDA cleared for sale in USA.

    FUSMobile announced that it received De Novo marketing authorization (DEN250015) from the FDA to begin marketing and sales of the Neurolyser XR system for...

    VahatiCor wins $23m for Coronary Microvascular Dysfunction device

    VahatiCor, a medtech company transforming cardiac care for Coronary Microvascular Dysfunction (CMD), announced the successful closing of its $23 million Series B financing led...

    FDA clears Levita’s Magnetic Surgical System for pediatric use

    Levita Magnetics has received FDA 510(k) clearance for its Magnetic Surgical System (MSS) to be used in certain pediatric surgeries, with the first U.S....

    Distalmotion raises $150M to support Dexter surgical robot as it targets ASCs

    Distalmotion closed a Series G financing round worth $150 million to support its Dexter surgical robot. Revival Healthcare Capital led the financing, which also...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    Vexev robotic ultrasound study meets endpoints

    Vexev and U.S. Renal Care announced successful results from the CANSCAN trial of the VxWave robotic ultrasound imaging system. Sydney, Australia-based Vexev develops the...

    Hyperion completes first-in-human study of Ivy robotic vascular access platform

    Hyperion Surgical announced today that it completed the world’s first robotic-assisted intravenous (IV) catheterisation using its Ivy platform. Ivy integrates advanced imaging, AI and robotic...

    AtriCure treats first patient in the BoxX-NoAF clinical trial

    AtriCure, a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced...

    Penumbra study backs Lightning Flash 2.0 mechanical thrombectomy system

    Penumbra announced positive results from its landmark STORM-PE randomised controlled trial. The study found that the use of the company’s computer-assisted vacuum thrombectomy (CAVT) system,...

    Innovation

    Regulatory Approvals

    Neurolyser XR now FDA cleared for sale in USA.

    FUSMobile announced that it received De Novo marketing authorization (DEN250015) from the FDA to begin marketing and sales of the Neurolyser XR system for...

    VahatiCor wins $23m for Coronary Microvascular Dysfunction device

    VahatiCor, a medtech company transforming cardiac care for Coronary Microvascular Dysfunction (CMD), announced the successful closing of its $23 million Series B financing led...

    FDA clears Levita’s Magnetic Surgical System for pediatric use

    Levita Magnetics has received FDA 510(k) clearance for its Magnetic Surgical System (MSS) to be used in certain pediatric surgeries, with the first U.S....

    Distalmotion raises $150M to support Dexter surgical robot as it targets ASCs

    Distalmotion closed a Series G financing round worth $150 million to support its Dexter surgical robot. Revival Healthcare Capital led the financing, which also...

    M&A

    Archives

    Latest articles